CoreRx Revenue and Competitors
Estimated Revenue & Valuation
- CoreRx's estimated annual revenue is currently $45.4M per year.
- CoreRx's estimated revenue per employee is $201,000
Employee Data
- CoreRx has 226 Employees.
- CoreRx grew their employee count by -5% last year.
CoreRx's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Science Officer | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Executive Director, Business Development | Reveal Email/Phone |
4 | CEO | Reveal Email/Phone |
5 | Executive Director, Human Resources | Reveal Email/Phone |
6 | Executive Director, Product Development | Reveal Email/Phone |
7 | Chief Strategy Officer (CSO) | Reveal Email/Phone |
8 | Executive Director Global Quality | Reveal Email/Phone |
9 | Warehouse Director | Reveal Email/Phone |
10 | Director Business Services | Reveal Email/Phone |
CoreRx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.5M | 132 | 8% | $1.4B | N/A |
#2 | $75M | 432 | 0% | N/A | N/A |
What Is CoreRx?
CoreRx® a CDMO with a focus on early phase drug product development, offering state of the art facilities to support your supply chain needs throughout the entire clinical trial process. Our integrated offerings provide comprehensive services for the development, manufacturing and testing of solid, liquid and semi-solid dosage forms. The art of drug product development is the core of what we do. We differentiate ourselves by mixing highly experienced scientists with a wide range of technologies to deliver optimal solutions to meet our clients needs. From simple formulations to complex, delayed or targeted release dosage forms, CoreRx's solutions maximize client investments, shorten development time and reduce overall costs. At CoreRx, you bring us your formulation challenge and we will supply the right ingredients to ensure your product reaches its maximum potential.
keywords:Biotechnology,Healthcare,PharmaceuticalsN/A
Total Funding
226
Number of Employees
$45.4M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CoreRx News
CoreRx Inc., a CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael,...
NovaQuest Private Equity acquired CoreRx, Inc., a Clearwater, FL-based global contract development and manufacturing organization. The amount of the deal was not disclosed. Goldman Sachs Specialty Lending Group provided debt financing for the transaction. Affiliates of Signet Healthcare Partner ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $65.1M | 234 | 15% | N/A |
#2 | $75.6M | 237 | 7% | N/A |
#3 | $73.7M | 248 | 5% | N/A |
#4 | $69M | 251 | 5% | N/A |
#5 | $59.4M | 257 | 10% | N/A |